How long can a patient with advanced cardia cancer live? How long can a patient with advanced cardia cancer live?

How long one can live with advanced cardia cancer varies from person to person, and is affected by many factors, such as the site of cancer cell metastasis, the patient's constitution, and sensitivity to drugs. Generally speaking, the survival period is relatively short, ranging from about a year to one or two months.

Cardiac cancer is a type of gastric cancer. When the disease develops to the late stage, it is often accompanied by symptoms of dysphagia, and it will also metastasize to the liver, lungs and other parts, so the survival period is generally short. So, how long can you live with late-stage cardia cancer?

How long can you live with advanced cardia cancer?

The survival period of late-stage cardia cancer varies from person to person and is often affected by many factors, such as the severity of the disease, the patient's physical condition, and the location of cancer cell metastasis. Generally speaking, in the late stage of cardia cancer, patients cannot eat normally, and insufficient nutrition will make their bodies weaker, resulting in a shorter survival time, which may be as long as about a year, or as short as one or two months, and they may die.

Factors affecting survival in advanced cardiac cancer

1. Cancer cell metastasis site

In the late stage of cardiac cancer, cancer cells will metastasize. Generally, the more sites of metastasis, the worse the prognosis and the shorter the survival period.

2. Patient's physical condition

The prognosis of advanced cardia cancer varies depending on the patient's physical condition, and the length of survival will also vary. Relatively speaking, young patients have better physical conditions and will survive longer than older patients.

3. Sensitivity to drugs

The main treatments for late-stage cardiac cancer are chemotherapy and targeted therapy. If the patient is sensitive to the drugs, the survival period will be longer. If the patient is not sensitive to the drugs and the progression of the disease cannot be controlled, the survival period will be shorter.